Re:Pair Genomics Inc.-preview

Repairgenomics

Re:Pair Genomics Inc.

Private

Vaughan, OntarioHealthcare & Life Scienceshttps://repairgenomics.com/

Last Round

Grant

Sep 16, 2025

Total Funding Raised

$40,810

Momentum Score

25 /100

Company Overview

Re:Pair Genomics Inc. is a biotechnology company that uses a machine-learning algorithm to design synthetic DNA sequences, such as promoters and enhancers, to target specific cell types for gene therapy applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

regulatory elementsgene therapyAI-driven designsynthetic promoterssynthetic enhancersgenerative biologysynthetic biologysynbiogene therapy componentscell-type targetingin silico designdrug discoverygene expressioncomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Re:Pair Genomics Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Re:Pair Genomics Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 16, 2025
Grant	Apr 4, 2025
Grant	Mar 27, 2025
Grant	Mar 10, 2025
Grant	Dec 2, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Luca Hategan

Chief Development Officer, Co-founder

Founding Team

Re:Pair Genomics Inc. Investors

Notable investors and investment history

Investor	Rounds
TechAlliance of Southwestern Ontario	Grant
i.d.e.a. Fund	Grant
Government of Canada	Grant
University of Toronto Entrepreneurship	Grant
Federal Economic Development Agency for Southern Ontario	Grant
RBCx	Grant
Centre for Aging and Brain Health Innovation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 1, 2026
Monthly visitors increased 133% MoM.
Sep 16, 2025
$1.5K grant from the Government of Canada.

View all signals

Re:Pair Genomics Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Re:Pair Genomics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Re:Pair Genomics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersVaughan, Ontario

Employee Range12

Year Founded2022

Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.